期刊文献+

自发性高血压大鼠心肌声学密度与心肌纤维化的关系及药物干预研究 被引量:1

Correlation between acoustic densitometry and myocardial fibrosis and effect of drug intervention on them
下载PDF
导出
摘要 目的探讨声学密度定量分析(AD)技术评估高血压心肌纤维化的价值,同时观察苯那普利和缬沙坦对高血压心肌纤维化的作用。方法10周龄的雄性自发性高血压大鼠(SHR)60只,随机分为SHR对照组(SHRc组)、SHR-苯那普利组(SHRb组)、SHR-缬沙坦组(SHRv组)和SHR-联合用药组(SHRb+v组),每组15只。用药组分别给予苯那普利、缬沙坦或二者半剂量合用灌胃10周,并以Wistar京都(WKY)大鼠15只为正常对照(WKY组)。应用AD技术获取各组大鼠左室相应部位心肌背向散射积分(IBS)与背向散射积分周期变化值(CVIB);测定其收缩压(SBP)、左室重量(LVM)以及左室重量指数(LVMI)和左室心肌羟脯氨酸浓度(HC);Masson染色观察心肌胶原含量变化,测量心肌胶原容积分数(CVF)和心肌内血管周围胶原面积(PVCA),并对所得指标进行相关分析。结果与WKY组相比,SHRc组大鼠SBP、LVM、LVMI、HC、CVF、PVCAI、BS均明显升高(P<0.01),而CVIB明显降低(P<0.01),三个用药组以上指标均明显改善(P<0.05,P<0.01)。除血压外,其他指标均以联合用药组改善最为显著(P<0.05,P<0.01)。相关分析显示,HC与CVF及PVCA均呈显著正相关(r=0.921、0.885,P<0.01)。室间隔及左室后壁IB%值与CVF(r=0.731、0.756,P<0.01)及PVCA(r=0.776、0.788,P<0.01)均呈显著正相关,而CVIB值与CVF(r=-0.642、-0.716,P<0.01)及PVCA(r=-0.720、-0.755,P<0.01)均呈显著负相关。结论AD技术是评估高血压心肌纤维化及其严重程度的一项可靠技术。苯那普利和缬沙坦可显著降低血压、减轻自发性高血压大鼠早期心肌纤维化,且二者合用可明显减轻心肌纤维化程度。 Objective To evaluate the quantitative acoustic densitometry(AD) technique in myocardial fibrosis diagnosis and to explore the effects of benazepril and valsartan on myocardial fibrosis.Methods Sixty ten-weekold male spontaneously hypertensive rats (SHRs) were randomly assigned to the control group(SHRc group),the benazepril group(SHRb group),the valsartan group(SHRv group) and the combination group(SHRb+v group),which were subjected to an intragastric administration for ten weeks.Fifteen male age-matched W...
出处 《山东大学学报(医学版)》 CAS 北大核心 2009年第1期50-55,共6页 Journal of Shandong University:Health Sciences
关键词 高血压 自发性高血压大鼠 声学密度 心肌纤维化 Hypertension Spontaneously hypertensive rat Acoustic densitometry Myocardial fibrosis
  • 相关文献

参考文献3

  • 1郑永红,白玉茹,胡锡衷,郑伟.小剂量联合应用缬沙坦和雷米普利对原发性高血压大鼠体内NO水平及心肌重塑的影响[J].中国全科医学,2007,10(3):211-214. 被引量:6
  • 2Bi Xiaojun,Deng Youbin,Pan Min,Yang Haoyi,Xiang Huijuan,Chang Qing,Li Chunlei. Influence of contractility on myocardial ultrasonic integrated backscatter and cyclic variation in integrated backscatter[J] 2002,Journal of Huazhong University of Science and Technology [Medical Sciences](3):233~234
  • 3K. Huber,O. Pachinger,M. Pichler,W. Klein. Pathophysiologische Mechanismen des Renin-Angiotensin-Systems und deren pharmakologische Beeinflussing durch ACE-Hemmer oder Angiotensin-II-(Typ-1-)Rezeptorblocker bei kardiovaskul?ren Erkrankungen[J] 1997,Zeitschrift für Kardiologie(4):239~250

二级参考文献8

  • 1Domenic A Sica.Combination angiotensin-converting enzyme inhibitor and angiotensin receptor blocker therapy:its role in clinical practice[J].J Clin Hypertens,2003,5:414-420.
  • 2Domenic A Sica.Combination ACE inhibitor and angiotensin receptor blocker therapy-future considerations[J].J Clin Hypertens,2007,9:78-86.
  • 3Stergiou GS,Skeva II,Baibas NM,et al.Additive hypotensive effect of angiotensin-converting enzyme inhibition and angiotensin-receptor antagonism in essential hypertension[J].J Cardiovasc Pharmacol,2000,35:937-941.
  • 4Weir MR,Weber MA,Neutel JM,et al.Efficacy of candesartan cilexetil as add-on therapy in hypertensive patients uncontrolled on background therapy:a clinical experience trial.ACTION Study Investigators[J].Am J Hypertens,2001,14:567-572.
  • 5Ke YS,Cao H,Yang T.Effect of combnation of valsartan with benazepril on blood pressure and 1eft ventricular hypertrophy in SHR[J].Acta Pharmacol Sin,2000,21:1043-1047.
  • 6Yagi S,Morita T,Katayama S.Combined treatment with an AT1 receptor blocker and angiotensin convertingenzyme inhibitor has an additive effect on inhibiting neointima formation via improvement of nitric oxide production and suppression of oxidative stress[J].Hypertens Res,2004,27:129-35.
  • 7Levy BI.Can angiotensin Ⅱ type 2 receptors have deleterious effects in cardiovascular disease[J]? Circulation,2004,109:8-13.
  • 8党爱民,陈改玲,刘国仗.高血压的药物治疗进展[J].中国全科医学,2004,7(10):691-693. 被引量:19

共引文献5

同被引文献10

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部